as on October 14, 2025 at 1:29 am IST
Day's Low
Day's High
3.44%
Downside
3.90%
Upside
52 Week's Low
52 Week's High
75.23%
Downside
342.66%
Upside
Check Sonnet Biotherapeutics Holdings Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$30.1M
EPS (TTM)
-3.46
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
0PEG Ratio
0EBITDA
-14.0M
Revenue (TTM)
1.0M
Profit Margin
0.00%
Return On Equity TTM
306943600.00%
Compare market cap, revenue, PE, and other key metrics of Sonnet Biotherapeutics Holdings Inc with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
---|---|---|---|---|---|
BUY | $30.1M | -99.93% | NA | 0.00% | |
BUY | $60.3B | 223.08% | -505.15 | -12.96% | |
NA | $37.8B | NA | NA | -3.89% | |
BUY | $104.6B | 50.07% | 28.98 | 31.86% | |
BUY | $59.8B | -7.17% | 14.23 | 31.37% |
The Sonnet Biotherapeutics Holdings Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Sonnet Biotherapeutics Holdings Inc investment value today
Current value as on today
₹99,774
Returns
Returns from Sonnet Biotherapeutics Holdings Inc Stock
Dollar Returns*
₹5,606 (+5.61%)
Based on 10 analysts
90.00%
Buy
10.00%
Hold
0.00%
Sell
Based on 10 analysts, 90% of analysts recommend a 'BUY' rating for Sonnet Biotherapeutics Holdings Inc. Average target price of $20
Get share price movements and forecasts by analysts on Sonnet Biotherapeutics Holdings Inc.
What analysts predicted
78.2%UPSIDE
Target Price
$20
Current Price
$4.36
Analyzed by
10 Analysts
Target
$20.00
Sonnet Biotherapeutics Holdings Inc target price $20, a slight upside of 78.2% compared to current price of $4.36. According to 10 analysts rating.
Investment in Sonnet Biotherapeutics Holdings Inc Shares on INDmoney has grown by 62.35% over the past 30 days, indicating increased transactional activity.
Time period: to
Change:62.35% versus previous 30 day period
Search interest for Sonnet Biotherapeutics Holdings Inc Stock has increased by 62% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:62% versus previous 30 day period
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Revenue Rich
Revenue is up for the last 3 quarters, 18.62K → 1.0M (in $), with an average increase of 85.9% per quarter
Against Peers
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 150.6% return, outperforming this stock by 248.6%
Against Peers
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 64.1% return, outperforming this stock by 69.7%
Profit Down
Netprofit is down for the last 4 quarters, -3.12M → -3.77M (in $), with an average decrease of 6.5% per quarter
Price Dip
In the last 7 days, SONN stock has moved down by -13.5%
Organisation | Sonnet Biotherapeutics Holdings Inc |
Headquarters | 100 Overlook Center, Princeton, NJ, United States, 08540 |
Industry | Consumer Services |
CEO | Mr. Raghu Rao |
E-voting on shares | Click here to vote |
Name | Title |
---|---|
Mr. Raghu Rao | Interim CEO & Director |
Dr. John K. Cini Ph.D. | Chief Scientific Officer & Co-Founder |
Mr. Donald J. Griffith CPA, CPA | CFO & Director |
Dr. Stephen J. McAndrew Ph.D. | President & Chief Business Officer |
Dr. Gael Hedou Ph.D. | Chief Operating Officer |
Ms. Susan Dexter | Chief Technical Officer |
Dr. Richard T. Kenney FACP, M.D. | Chief Medical Officer |
Mr. Manuel Dafonseca | Head of Clinical Operations |
Sonnet Biotherapeutics Holdings Inc share price today is $4.36 as on at the close of the market. Sonnet Biotherapeutics Holdings Inc share today touched a day high of $4.53 and a low of $4.21.
Sonnet Biotherapeutics Holdings Inc share touched a 52 week high of $19.3 on and a 52 week low of $1.08 on . Sonnet Biotherapeutics Holdings Inc stock price today i.e. is closed at $4.36,which is 77.41% down from its 52 week high and 303.70% up from its 52 week low.
Sonnet Biotherapeutics Holdings Inc market capitalisation is $0.00T as on .
Indian investors can start investing in Sonnet Biotherapeutics Holdings Inc (SONN) shares with as little as ₹88.635 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹886.35 in Sonnet Biotherapeutics Holdings Inc stock (as per the Rupee-Dollar exchange rate as on ).
Based on Sonnet Biotherapeutics Holdings Inc share’s latest price of $4.36 as on October 14, 2025 at 1:29 am IST, you will get 2.2936 shares of Sonnet Biotherapeutics Holdings Inc. Learn more about
fractional shares .
Sonnet Biotherapeutics Holdings Inc stock has given -99.93% share price returns and 21.02% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?